Public SEC Form D records
Biotech Form D filings - July 2026
This page lists the 89 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers in July 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 89
- Issuers
- 85
- Combined disclosed
- $1.7B
Directory links
Filing records
89 crawlable filing links in this facet.
- Enumera Molecular, Inc.July 31, 2026 / Reg D 506(b) / MI$17.4M
- Ratio Therapeutics, Inc.July 31, 2026 / Reg D 506(b) / MA$70.0M
- ORF Biologics, Inc.July 31, 2026 / Reg D 506(b) / IA$2.5M
- Conexeu Sciences Inc.July 31, 2026 / Reg D 506(b) / NV$62.7K
- Mangrove Therapeutics Inc.July 31, 2026 / Reg D 506(b) / CA$5.0M
- PushCART Therapeutics, Inc.July 31, 2026 / Reg D 506(b) / MD$2.0M
- Genomenon, Inc.July 30, 2026 / Reg D 506(b) / MI$10.0M
- Trailhead Biosystems Inc.July 30, 2026 / Reg D 506(b) / OH$40.4M
- Trailhead Biosystems Inc.July 30, 2026 / Reg D 506(b) / OH$40.6M
- NextPoint Therapeutics, Inc.July 30, 2026 / Reg D 506(b) / MA$48.7M
- Biota Inc.July 30, 2026 / Reg D 506(b) / CO$3.2M
- Born Science, LLCJuly 29, 2026 / Reg D 506(b) / TX$5.0M
- ImmuNovus, Inc.July 29, 2026 / Reg D 506(b) / NE$5.0M
- ImmuNovus, Inc.July 29, 2026 / Reg D 506(b) / NE$5.0M
- Dravite Therapeutics, Inc.July 28, 2026 / Reg D 506(b) / CA$15.0M
- MiNDERA CorpJuly 28, 2026 / Reg D 506(b) / CA$50.0M
- Biosceptre International LtdJuly 28, 2026 / Reg D 506(b)$346.0K
- Pharmazz, Inc.July 28, 2026 / Reg D 506(b) / IL$3.5M
- Accipiter Biosciences Inc.July 28, 2026 / Reg D 506(b) / WA$10.5M
- ESTRIGENIX THERAPEUTICS, INC.July 27, 2026 / Reg D 506(b) / WI$2.0M
- Simbryo Technologies, Inc.July 27, 2026 / Reg D 506(b) / TX$5.3M
- AFFINITY BIOSENSORS LLCJuly 24, 2026 / Reg D 506(b) / CA$10.0M
- ASCENDIA PHARMACEUTICALS, INC.July 24, 2026 / Reg D 506(b) / NJ$4.1M
- Embold Therapeutics, Inc.July 24, 2026 / Reg D 506(b) / CA$5.0M
- Allotera Therapeutics, Inc.July 23, 2026 / Reg D 506(b) / MO$163.0M
- BioGene Therapeutics Inc.July 23, 2026 / Reg D 506(b) / TX$4.5M
- Angelis Oncology, Inc.July 23, 2026 / Reg D 506(b) / CAUndisclosed
- Holobiome, Inc.July 22, 2026 / Reg D 506(b) / MA$10.0M
- Oncotelic Therapeutics, Inc.July 22, 2026 / Reg D 506(b) / CA$711.8K
- Cue Biopharma, Inc.July 22, 2026 / Reg D 506(b) / MA$50.0M
- Rhoshan Pharmaceuticals, Inc.July 22, 2026 / Reg D 506(b) / PA$3.2M
- Pike Therapeutics Inc.July 21, 2026 / Reg D 506(b)$760.0K
- InterAct Therapeutics, Inc.July 21, 2026 / Reg D 506(b) / TX$2.0M
- ALZpath, Inc.July 21, 2026 / Reg D 506(b) / CA$10.4M
- Precision Peptide Co Inc.July 20, 2026 / Reg D 506(b)$883.4K
- CollPlant Biotechnologies LtdJuly 20, 2026 / Reg D 506(b)$10.4M
- Anavatos Bio Inc.July 20, 2026 / Reg D 506(b) / WAUndisclosed
- Deep Root Biolabs, Inc.July 20, 2026 / Reg D 506(b) / MD$2.5M
- AB Science S.A.July 17, 2026 / Reg D 506(b)$2.0M
- Aspicio Therapeutics, Inc.July 17, 2026 / Reg D 506(b) / PA$200.0K
- AVSF - Alloy Therapeutics 2026, LLCJuly 17, 2026 / Reg D 506(b) / MAUndisclosed
- Rigora Clinical Inc.July 17, 2026 / Reg D 506(b) / CA$750.0K
- CYBIN INC.July 16, 2026 / Reg D 506(b)$511.7K
- CYBIN INC.July 16, 2026 / Reg D 506(b)Undisclosed
- AdvanCell, Inc.July 16, 2026 / Reg D 506(b) / MA$315.0M
- Baylor Genetics Holdings, Inc.July 16, 2026 / Reg D 506(b) / TX$100.0M
- OS Therapies IncJuly 16, 2026 / Reg D 506(b) / MD$9.3M
- Glycotest Inc.July 16, 2026 / Reg D 506(b) / PA$6.8M
- Sinopia Biosciences, Inc.July 16, 2026 / Reg D 506(b) / CA$4.3M
- Cambrian BioPharma IncJuly 15, 2026 / Reg D 506(c) / NY$129.8M
- Cadrenal Therapeutics, Inc.July 15, 2026 / Reg D 506(b) / FL$8.8M
- Cellular Logistics, Inc.July 15, 2026 / Reg D 506(b) / WI$100.0K
- LYNCH REGENERATIVE MEDICINE, LLCJuly 15, 2026 / Reg D 506(b) / TN$17.5M
- SelSym Biotech, Inc.July 15, 2026 / Reg D 506(b) / NC$1.5M
- Silo Pharma, Inc.July 14, 2026 / Reg D 506(b) / FL$4.0M
- ImmunoVec, Inc.July 14, 2026 / Reg D 506(b) / CA$15.0M
- Laxmi Therapeutic Devices, Inc.July 14, 2026 / Reg D 506(b) / CA$2.1M
- FORE US Bio Inc.July 14, 2026 / Reg D 506(b) / PA$109.6M
- Dash Bio, Inc.July 14, 2026 / Reg D 506(b) / MA$30.0M
- Nerveli Inc.July 14, 2026 / Reg D 506(b) / TX$500.0K
- Reticle Biosystems, Inc.July 14, 2026 / Reg D 506(b) / CA$1.0M
- Neurofold Therapeutics Inc.July 14, 2026 / Reg D 506(b) / CO$6.5M
- Tianzheng Biotechnology IncJuly 14, 2026 / Reg D 504 / CO$5.0M
- Sailie Bio, Inc.July 14, 2026 / Reg D 506(b) / MA$250.0K
- Dewpoint Therapeutics, Inc.July 13, 2026 / Reg D 506(b) / MA$82.3M
- Pluristyx Inc.July 13, 2026 / Reg D 506(b) / WA$14.8M
- OurPharma Holdings LLCJuly 10, 2026 / Reg D 506(b) / AR$3.5M
- Amlogenyx Inc.July 9, 2026 / Reg D 506(b) / CA$20.0M
- AKADEUM LIFE SCIENCES, INC.July 9, 2026 / Reg D 506(b) / MI$3.4M
- CeleCor Therapeutics, Inc.July 9, 2026 / Reg D 506(b) / CA$15.0M
- MicroPure Genomics, Inc.July 8, 2026 / Reg D 506(b) / CA$2.0M
- Chronicle Bio, Inc.July 7, 2026 / Reg D 506(b) / CA$15.0M
- Medicenna Therapeutics Corp.July 6, 2026 / Reg D 506(b)$2.3M
- 65 Therapeutics, Inc.July 6, 2026 / Reg D 506(b) / MA$6.7M
- CELESTIAL THERAPEUTICS INC.July 6, 2026 / Reg D 506(c) / CAUndisclosed
- PridCor Therapeutics, LLCJuly 6, 2026 / Reg D 506(b) / AL$6.0M
- Myrtelle Inc.July 2, 2026 / Reg D 506(b) / NY$30.0M
- CYduct Diagnostics, Inc.July 2, 2026 / Reg D 506(b) / CT$2.0M
- Mati Therapeutics Inc.July 2, 2026 / Reg D 506(b) / TX$4.9M
- Cognos Therapeutics IncJuly 2, 2026 / Reg D 506(b) / CA$2.0M
- Lungpacer Medical, Inc.July 2, 2026 / Reg D 506(b) / PA$20.0M
- NurExone Biologic Inc.July 2, 2026 / Reg D 506(b)$441.8K
- Aevius Labs, Inc.July 2, 2026 / Reg D 506(b) / MA$2.0M
- HOPE-Neuron Therapeutx, Inc.July 2, 2026 / Reg D 506(b) / AZ$150.0K
- Jaguar Health, Inc.July 1, 2026 / Reg D 506(b) / CA$40.8M
- Jaguar Health, Inc.July 1, 2026 / Reg D 506(b) / CA$2.0M
- AQUABOUNTY TECHNOLOGIES INCJuly 1, 2026 / Reg D 506(b) / MA$2.3M
- Reprise Biomedical, Inc.July 1, 2026 / Reg D 506(b) / MN$10.0M
- Andros Medicines Inc.July 1, 2026 / Reg D 506(b) / MA$5.0M